Chang, Kun <br/><br/>
Combination of circulating tumor cell enumeration and tumor marker detection in predicting prognosis and treatment effect in metastatic castration-resistant prostate cancer.  [electronic resource] 

 -  Oncotarget  Dec 2015 
 - 41825-36 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.6167  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Biomarkers, Tumor--blood<br/>Cell Count<br/>Cell Line, Tumor<br/>Disease-Free Survival<br/>Docetaxel<br/>Epithelial-Mesenchymal Transition--drug effects<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Kallikreins--blood<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Neoplasm Metastasis<br/>Neoplastic Cells, Circulating--drug effects<br/>Neoplastic Stem Cells--chemistry<br/>Predictive Value of Tests<br/>Prednisone--administration & dosage<br/>Proportional Hazards Models<br/>Prospective Studies<br/>Prostate-Specific Antigen--blood<br/>Prostatic Neoplasms, Castration-Resistant--blood<br/>Real-Time Polymerase Chain Reaction<br/>Reproducibility of Results<br/>Risk Factors<br/>Serum Albumin--analysis<br/>Serum Albumin, Human<br/>Taxoids--administration & dosage<br/>Time Factors<br/>Treatment Outcome